Country: Канада
Језик: Енглески
Извор: Health Canada
PHENYLEPHRINE HYDROCHLORIDE
ODAN LABORATORIES LTD
S01FB01
PHENYLEPHRINE
2.5%
SOLUTION
PHENYLEPHRINE HYDROCHLORIDE 2.5%
OPHTHALMIC
15ML
OTC
MYDRIATICS
Active ingredient group (AIG) number: 0100662002; AHFS:
APPROVED
2015-10-14
PRESCRIBING INFORMATION ODAN-PHENYLEPHRINE PHENYLEPHRINE HYDROCHLORIDE OPHTHALMIC SOLUTION USP 2.5% MYDRIATIC / VASOCONSTRICTOR ODAN LABORATORIES LTD. 325 Stillview Ave., Pointe-Claire, Québec H9R 2Y6 Control No: 188055 Date of Preparation: October 14, 2015 www.odanlab.com 2 PRESCRIBING INFORMATION ODAN-PHENYLEPHRINE PHENYLEPHRINE HYDROCHLORIDE OPHTHALMIC SOLUTION USP 2.5% DESCRIPTION ODAN-PHENYLEPHRINE is a sterile ophthalmic solution containing a sympathomimetic agent which produces both vasoconstricting and mydriatic effects. Phenylephrine hydrochloride is a synthetic sympathomimetic compound structurally similar to epinephrine and ephedrine. A prompt, short acting mydriatic, it causes little or no cycloplegia or irritation. ACTIONS Phenylephrine hydrochloride is presumed to have a direct effect upon the alpha-adrenergic receptor stimulator producing pupil dilation and vasocontriction. INDICATIONS As an ophthalmic decongestant and vasoconstrictor for pupil dilation in uveitis (posterior synechiae), wide angle glaucoma, surgery, refraction, ophthalrnoscopic examination and diagnostic procedures. CONTRAINDICATIONS Narrow-angle glaucoma, hypertension, and in persons with a known hypersensitivity to any component. WARNINGS For topical ophthalmic use only. As with all other adrenergic drugs, when administered simultaneously with, or up to 21 days after, administration of monoamine 1oxidase (MAO) inhibitors, careful supervision and adjustment of dosages are required since exaggerated adrenergic effects may result. The pressor response of adrenergic agents may also be potentiated by tricyclic antidepressants . 3 PRECAUTIONS ODAN-PHENYLEPHRINE should be used with caution in patients with advanced arteriosclerotic conditions or severe hypertension. Phenylephrine may be used in patients with glaucoma when temporary dilation of the pupil may free adhesions or when vasocontriction of intrinsic vessels may lower intraocular tension: these advantages may temporarily outweigh the danger from coincident dilation of the pupil Прочитајте комплетан документ